Literature DB >> 1429211

Tumor necrosis factor-alpha stimulates colony formation by a megakaryoblastic leukemia cell line, CMK.

Y Akiyama1, K Yamaguchi, T Sato, K Abe.   

Abstract

The CMK cell line is an acute megakaryoblastic leukemia cell line established from a patient with Down's syndrome, and is known to possess characteristics of normal megakaryocytes. Several cytokines with the ability to stimulate megakaryopoiesis, such as interleukin-3 (IL-3), interleukin-6 (IL-6) and granulocyte-macrophage colony-stimulating factor (GM-CSF), stimulated colony formation by CMK cells. The present study revealed that tumor necrosis factor-alpha (TNF-alpha) stimulated colony formation by CMK cells; the potency was almost equal to that of IL-3, IL-6 or GM-CSF. Scatchard plot analysis revealed that CMK cells possess two types of specific binding sites for TNF-alpha. The high-affinity binding sites had an affinity constant of 0.18 nM, and numbered 5,000. The low-affinity binding sites had an affinity constant of 1.8 nM and numbered 19,000. These results raise the possibility that TNF-alpha can act as a growth-stimulating agent on megakaryocyte-lineage cell line.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429211      PMCID: PMC5918975          DOI: 10.1111/j.1349-7006.1992.tb02012.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


megakaryocyte colony‐stimulating factor interleukin‐3 granulocyte‐macrophage colony‐stimulating factor interleukin‐6 interleukin‐lα interleukin‐1β tumor necrosis factor‐α fetal bovine serum dissociation constant enzyme‐linked immunosorbent assay
  27 in total

1.  Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand.

Authors:  K Imamura; D Spriggs; D Kufe
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

2.  Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells.

Authors:  T Murase; T Hotta; H Saito; R Ohno
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

Review 3.  Peptide growth factors are multifunctional.

Authors:  M B Sporn; A B Roberts
Journal:  Nature       Date:  1988-03-17       Impact factor: 49.962

4.  Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells.

Authors:  C Caux; S Saeland; C Favre; V Duvert; P Mannoni; J Banchereau
Journal:  Blood       Date:  1990-06-15       Impact factor: 22.113

5.  Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia.

Authors:  W Digel; M Stefanic; W Schöniger; C Buck; A Raghavachar; N Frickhofen; H Heimpel; F Porzsolt
Journal:  Blood       Date:  1989-04       Impact factor: 22.113

6.  Molecular cloning and expression of a receptor for human tumor necrosis factor.

Authors:  T J Schall; M Lewis; K J Koller; A Lee; G C Rice; G H Wong; T Gatanaga; G A Granger; R Lentz; H Raab
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

7.  Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha).

Authors:  H P Hohmann; R Remy; M Brockhaus; A P van Loon
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

8.  A T-cell line derived from normal human cord leukocytes by co-culturing with human leukemic T-cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; Y Shiraishi
Journal:  Gan       Date:  1981-12

9.  Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies.

Authors:  F T Cordingley; A Bianchi; A V Hoffbrand; J E Reittie; H E Heslop; A Vyakarnam; M Turner; A Meager; M K Brenner
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

10.  Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.

Authors:  J Vilcek; V J Palombella; D Henriksen-DeStefano; C Swenson; R Feinman; M Hirai; M Tsujimoto
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  4 in total

1.  Stem-cell factor regulates the expression of cyclin A and retinoblastoma gene product in the growth and differentiation pathway of human megakaryocytic cells.

Authors:  E Shimizu; Y Takahashi; A Shinohara; Y Yamamoto; S Yoshida; A Yamamoto; S Sone; Y Takaue; T Ogura
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Cytokine production by a megakaryocytic cell line.

Authors:  B Sandrock; K M Hudson; D E Williams; M A Lieberman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-04       Impact factor: 2.416

3.  In vivo effect of recombinant human leukemia inhibitory factor in primates.

Authors:  Y Akiyama; N Kajimura; J Matsuzaki; Y Kikuchi; N Imai; M Tanigawa; K Yamaguchi
Journal:  Jpn J Cancer Res       Date:  1997-06

4.  Protective effect of recombinant human leukemia inhibitory factor against thrombocytopenia in carboplatin-treated mice.

Authors:  Y Akiyama; Y Kikuchi; J Matsuzaki; N Kajimura; C Ohue; K Yamaguchi
Journal:  Jpn J Cancer Res       Date:  1997-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.